- 
        Taxonomy & unit
      
 
      - 
        us-gaap: USD
      
 
    
    
      
- 
        Description
      
 
      - 
        The net result for the period of deducting operating expenses from operating revenues.
      
 
    
    
      - 
        Summary
      
 
      - 
        Regenerx Biopharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2022.
- Regenerx Biopharmaceuticals Inc Operating Income (Loss) for the quarter ending March 31, 2023 was -$305K, a 11.3% increase year-over-year.
 - Regenerx Biopharmaceuticals Inc Operating Income (Loss) for the twelve months ending March 31, 2023 was -$1.36M, a 0.72% increase year-over-year.
 - Regenerx Biopharmaceuticals Inc annual Operating Income (Loss) for 2022 was -$1.4M, a 5.53% decline from 2021.
 - Regenerx Biopharmaceuticals Inc annual Operating Income (Loss) for 2021 was -$1.33M, a 2.62% decline from 2020.
 - Regenerx Biopharmaceuticals Inc annual Operating Income (Loss) for 2020 was -$1.29M, a 2.59% decline from 2019.
 
       
     
   
    
  Operating Income (Loss), Trailing 12 Months (USD)
  
  
  Operating Income (Loss), Annual (USD)
  
    
  Operating Income (Loss), YoY Annual Growth (%)